SCIENTIFIC publications

/cun/en/investigacion/publicaciones-cientificas/areaMain/02
  • Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer

    Ponz-Sarvise M (1), Corbo V (2), Tiriac H (3), Engle DD (4), Frese KK (5), Oni TE (6), Hwang CI (3), Öhlund D (7), Chio IIC (8), Baker LA (3), Filippini D (3), Wright K (3), Bapiro TE (9), Huang PS (10), Smith PD (11), Yu KH (12), Jodrell DI (13), Park Y (3), Tuveson DA (14).

    (1) Medical Oncology, Clinica Universidad de Navarra, Universidad de Navarra.
    (2) Diagnostics and Public Health, ARC-Net Research Centre, University and Hospital Trust of Verona.
    (3) Cold Spring Harbor Laboratory.
    (4) Regulatory Biology Laboratory, Salk Institute for Biological Studies.
    (5) Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute.
    (6) Cancer Center, Cold Spring Harbor Laboratory.
    (7) Wallenberg Centre for Molecular Medicine, Umeå University.
    (8) Genetics and Development, Columbia University.
    (9) CRUK Cambridge Institute, University of Cambridge.
    (10) G&A, Cygnal Therapeutics.
    (11) Oncology Bioscience, AstraZeneca (United Kingdom).
    (12) Medicine, Memorial Sloan Kettering Cancer Center.
    (13) Cancer Research UK Cambridge Institute, University of Cambridge.
    (14) Cold Spring Harbor Laboratory

    Clinical Cancer Research 06 SEPTEMBER 2019

  • Increase of the Adiponectin/Leptin Ratio in Patients with Obesity and Type 2 Diabetes after Roux-en-Y Gastric Bypass

    Unamuno X (1,2), Izaguirre M (1), Gómez-Ambrosi J (1,2,3), Rodríguez A (1,2,3), Ramírez B (1,2,3), Becerril S (1,2,3), Valentí V (2,3,4), Moncada R (2,3,5), Silva C (2,6), Salvador J (2,6), Portincasa P (7), Frühbeck G (1,2,3,6), Catalán V (8,9,10).

    (1) Metabolic Research Laboratory, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
    (2) CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 31008 Pamplona, Spain.
    (3) Obesity and Adipobiology Group, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain.
    (4) Department of Surgery, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
    (5) Department of Anesthesia, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
    (6) Department of Endocrinology & Nutrition, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
    (7) Clinica Medica "A. Murri", Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro" Medical School, 70124 Bari, Italy.
    (8) Metabolic Research Laboratory, Clínica Universidad de Navarra, 31008 Pamplona, Spain.
    (9) CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 31008 Pamplona, Spain.
    (10) Obesity and Adipobiology Group, Instituto de Investigación Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain. 

    Nutrients 03 SEPTEMBER 2019

  • Identification of 58 Mutations (26 Novel) in 94 of 109 Symptomatic Spanish Probands with Protein C Deficiency

    Martos L (#1), Fernández-Pardo Á (#1), López-Fernández MF (2), Ibáñez F (3), Herrero S (4), Tàssies D 5, González-Porras JR (6), Solmoirago MJ (1), Costa MJ (2), Reverter JC (5), Marco P (7), Roldán V (8), Lecumberri R (9), Velasco F (10), Oto J (1), Iruin G (11), Alonso MN (12), Vayá A (1), Bonanad S (1,13), Ferrando F (1,13), Martí E (14), Cid AR (1,13), Plana E (1), Oña F (15), Cuesta I (16), González-López TJ (17), España F (1), Medina P (1), Navarro S (1); Working Group of the Spanish Society of Thrombosis Haemostasis (SETH).

    (1) Grupo de Investigación en Hemostasia, Trombosis, Arteriosclerosis y Biología Vascular, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Hospital Universitario y Politécnico La Fe, Valencia, Spain.
    (2) Complejo Hospitalario Universitario A Coruña, A Coruña, Spain.
    (3) Hospital General Universitario de Valencia, Valencia, Spain.
    (4) Hospital Universitario de Guadalajara, Guadalajara, Spain.
    (5) Hospital Clinic de Barcelona, Barcelona, Spain.
    (6) Hospital Universitario de Salamanca-IBSAL, Salamanca, Spain.
    (7) Hospital General Universitario de Alicante, Alicante, Spain.
    (8) Hospital General Universitario Morales Meseguer, Murcia, Spain.
    (9) Clínica Universidad de Navarra, Pamplona, Spain.
    (10) Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.
    (11) Hospital de Cruces, Baracaldo, Bilbao, Spain.
    (12) Hospital Universitario Infanta Cristina, Badajoz, Spain.
    (13) Unidad de Trombosis y Hemostasia, Servicio de Hematología, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
    (14) Hospital de Manises, Valencia, Spain.
    (15) Hospital Universitario de Getafe, Getafe, Madrid, Spain.
    (16) Hospital Obispo Polanco, Teruel, Spain.
    (17) Hospital Universitario de Burgos y Departamento de Ciencias de la Salud, Universidad de Burgos, Burgos, Spain.
    # Contributed equally

    Thrombosis and Haemostasia 01 SEPTEMBER 2019

  • Improvement of the Elevated Tryptase Criterion to Discriminate IgE- From Non-IgE-Mediated Allergic Reactions

    Gastaminza G (1), Lafuente A (2), Goikoetxea MJ (1), D'Amelio CM (1), Bernad-Alonso A (1), Vega O (1), Martinez-Molina JA (2), Ferrer M (1), Nuñez-Cordoba JM (3).

    (1) From the Departments of Allergology and Clinical Immunology.
    (2) Anaesthesia.
    (3) Research Support Service, Central Clinical Trials Unit, Clínica Universidad de Navarra, Pamplona, Spain.

    Anesthesia and Analgesia 16 AUGUST 2019

  • Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma

    Ricke J (1), Klumpen HJ (2), Amthauer H (3), Bargellini I (4), Bartenstein P (5), de Toni E (6), Gasbarrini A (7), Pech M (8), Peck-Radosavljevic M (9), Popovič P (10), Rosmorduc O (11), Schott E (12), Seidensticker M (13), Verslype C (14), Sangro B (15), Malfertheiner P (16).

    (1) Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
    (2) Department of Medical Oncology, Amsterdam University Medical Centers, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
    (3) Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
    (4) Department of Interventional Radiology, Pisa University Hospitalvia Paradisa 2, 56100 Pisa, Italy.
    (5) Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
    (6) Department of Medicine II, Liver Center Munich, University Hospital, Munich, Germany.
    (7) Internal Medicine, Gastroenterology and Hepatic Diseases Unit, IRCCS Fondazione Policlinico Universitario A. Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy.
    (8) Department of Radiology and Nuclear Medicine, University of Magdeburg, Leipziger Str.44, 39120, Magdeburg, Germany.
    (9) Department of Internal Medicine and Gastroenterology, Klinikum Klagenfurt am Wörthersee, Klagenfurt, Austria.
    (10) Clinical Institute of Radiology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
    (11) APHP, Hôpital La Pitié Salpêtrière, Service d'Hépato-Gastroentérologie, Paris, France.
    (12) Department of Gastroenterology, Hepatology and Diabetology, Internal Medicine II, HELIOS Hospital Emil von Behring, Berlin, Germany.
    (13) University Hospital, LMU Munich, Munich, Germany.
    (14) Department of Digestive Oncology, University Hospital Leuven, Leuven, Belgium.
    (15) Liver Unit, Clinica Universidad de Navarra-IDISNA and CIBEREHD, Pamplona, Spain.
    (16) Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.

    Journal of Hepatology 14 AUGUST 2019

you mayBE INTERESTED

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra